| Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231) |
|---|
| 08/20/2002 | US6436656 Method for screening a test compound for potential as an immunosuppressive drug candidate |
| 08/20/2002 | US6436655 Rapid quantitative measurement of soluble fibrin in opaque body fluids |
| 08/20/2002 | US6436652 Method of detecting a pathogen using a virus |
| 08/20/2002 | US6436649 Method for detecting and/or quantifying a hapten in a homogeneous phase and device for implementation thereof |
| 08/20/2002 | US6436647 Method for detecting chemical interactions between naturally occurring biological analyte molecules that are non-identical binding partners |
| 08/20/2002 | US6436646 Contacting target nucleic acid sequence with complementary labeled probe; molecular hybridization increases level of polycation |
| 08/20/2002 | US6436645 Method for predicting risk of developing chronic pulmonary emphysema |
| 08/20/2002 | US6436642 Method of classifying a thyroid carcinoma using differential gene expression |
| 08/20/2002 | US6436641 Electrophoresis and medium for separation of chain termination fragments; optic section, excitation source, and light detector; data processing; computers; genetic engineering |
| 08/20/2002 | US6436640 Use of LNA in mass spectrometry |
| 08/20/2002 | US6436638 Cryptosporidium detection method |
| 08/20/2002 | US6436637 Polynucleotide; expression vector; antiinflammatory agents; cell proliferative and apoptosis disorder treatment |
| 08/20/2002 | US6436635 Solid phase sequencing of double-stranded nucleic acids |
| 08/20/2002 | US6436634 Compositions and methods for inhibiting human immunodeficiency virus infection by down-regulating human cellular genes |
| 08/20/2002 | US6436631 Comparative phenotype analysis for assessment of biologically active compounds such as antimicrobials |
| 08/20/2002 | US6436630 Drug screening by exposing gastropod foot to substance; qualitative and quantitative analysis; evaluating irritation to mucous membranes; high speed, accuracy |
| 08/20/2002 | US6436629 Modulating angiogenesis |
| 08/20/2002 | US6436628 Methods of identifying an agent which modulates period and doubletime protein interaction |
| 08/20/2002 | US6436410 DNA encoding neospora dihydrofolate reductase-thymidylate synthase |
| 08/20/2002 | US6436394 Adenovirus vectors specific for cells expressing androgen receptor and methods of use thereof |
| 08/20/2002 | US6436355 Electrically conducting polymer capable of emitting heat when an electric current is passed through it; reagent container, such as a capillary tube, slide or chip, in close contact with the polymer; for polymerase chain reaction |
| 08/20/2002 | US6436255 Quantitative analysis; using oxidoreductase enzyme |
| 08/20/2002 | CA2340475C Orphan receptor |
| 08/20/2002 | CA2250263C Human netrin-1 |
| 08/20/2002 | CA2238283C Method for identifying compounds for inhibition of neoplastic lesions, pharmaceutical compositions from such compounds and uses of such compounds and compositions for treating neoplastic lesions |
| 08/20/2002 | CA2145664C Oligonucleotides having a conserved g4 core sequence |
| 08/20/2002 | CA2059124C Platelet aggregation inhibitors |
| 08/19/2002 | CA2354197A1 Identification of nucleotide sequences specific for mycobacteria and development of differential diagnosis strategies for mycobacterial species |
| 08/15/2002 | WO2002063310A1 Biochip and method of manufacturing the biochip |
| 08/15/2002 | WO2002063307A2 Methods of assessing wolframin protein activity |
| 08/15/2002 | WO2002063303A1 Screening method using solid supports modified with self-assembled monolayers |
| 08/15/2002 | WO2002063301A1 Method and apparatus to identify small variations of biomolecules |
| 08/15/2002 | WO2002063299A1 Low affinity screening method |
| 08/15/2002 | WO2002063298A2 Gap junction permeability assay |
| 08/15/2002 | WO2002063049A2 Methods for determining a nucleotide at a specific location within a nucleic acid molecule |
| 08/15/2002 | WO2002063048A2 Methods for predicting sensitivity of tumors to arginine deprivation |
| 08/15/2002 | WO2002063047A1 Novel molecules of the card-related protein family and uses thereof |
| 08/15/2002 | WO2002063046A1 Haplotypes of the tacr2 gene |
| 08/15/2002 | WO2002063045A1 Drug target isogenes: polymorphisms in the angiotensin receptor 2 gene |
| 08/15/2002 | WO2002063044A2 Haplotypes of the il15 gene |
| 08/15/2002 | WO2002063043A1 Multitemperature single strand conformation polymorphism (msscp) |
| 08/15/2002 | WO2002063041A1 Mixed intercalator and electrochemical detection of dna using same |
| 08/15/2002 | WO2002063040A2 Method for the isolation of extrachromosomal dna and for the use of said dna for diagnosing pathologies |
| 08/15/2002 | WO2002063038A1 Method for identifying compounds modulating reverse cholesterol transport |
| 08/15/2002 | WO2002063037A2 Method for identifying functional nucleic acids |
| 08/15/2002 | WO2002063036A2 Vector system used in screening active substances |
| 08/15/2002 | WO2002063035A2 Fluorescent assay for proteolysis |
| 08/15/2002 | WO2002063032A1 Methods and kits for identifying scavengers of reactive oxygen species (ros) |
| 08/15/2002 | WO2002063030A2 Charge tags and separation of nucleic acid molecules |
| 08/15/2002 | WO2002063020A2 Soybean plants with enhanced yields and methods for breeding for and screening of soybean plants with enhanced yields |
| 08/15/2002 | WO2002063018A2 Method for the production of plant seed with modified fibre content and modified seed coat |
| 08/15/2002 | WO2002063013A2 Human acid phosphatase gene |
| 08/15/2002 | WO2002063008A2 Intracellular signaling molecules |
| 08/15/2002 | WO2002063007A2 TIMM8b-RELATED PROTEIN |
| 08/15/2002 | WO2002063006A2 Receptors and membrane-associated proteins |
| 08/15/2002 | WO2002063005A2 Lipid-associated molecules |
| 08/15/2002 | WO2002063004A2 G-protein coupled receptors |
| 08/15/2002 | WO2002062999A2 Proteins and nucleic acids encoding same |
| 08/15/2002 | WO2002062993A1 Amplified nucleic acids and immobilized products thereof |
| 08/15/2002 | WO2002062967A2 Multipotent o-2a progenitors from the neurohypophysis |
| 08/15/2002 | WO2002062963A2 Methods and compounds for treating neurologic or neuropsychiatric disorders and identifying compounds to treat the same |
| 08/15/2002 | WO2002062960A2 Cell fusion assays for the identification of antiviral compounds, and systems and kits for practicing the same |
| 08/15/2002 | WO2002062958A2 Prc17: an amplified cancer gene |
| 08/15/2002 | WO2002062957A2 Ter sites and ter binding proteins |
| 08/15/2002 | WO2002062956A2 Chemomagnetic retrieval of cmv and cmv infected cells |
| 08/15/2002 | WO2002062952A2 Non-cytotoxic pap mutants |
| 08/15/2002 | WO2002062950A2 Method for quantification of recombinant viruses |
| 08/15/2002 | WO2002062945A2 Compositions and methods relating to lung specific genes and proteins |
| 08/15/2002 | WO2002062942A2 Filtration assembly |
| 08/15/2002 | WO2002062941A1 Detection of micro-organisms |
| 08/15/2002 | WO2002062841A2 Secreted proteins |
| 08/15/2002 | WO2002062840A1 INTERFERON-α INDUCED GENE |
| 08/15/2002 | WO2002062839A2 Markers of unstable atherosclerotic plaques |
| 08/15/2002 | WO2002062836A2 Detection of antibacterial activity in excretory secretory product of adult trichuris suis |
| 08/15/2002 | WO2002062834A2 Mixture of peptides originating from a nef protein and applications thereof |
| 08/15/2002 | WO2002062825A2 Detection of polymorphisms in the human 5-lipoxygenase gene |
| 08/15/2002 | WO2002062822A2 Methods of identifying regulator molecules |
| 08/15/2002 | WO2002062821A2 Peptide or protein microassay method and apparatus |
| 08/15/2002 | WO2002062820A2 Haplotypes of the cyp27b1 gene |
| 08/15/2002 | WO2002062370A2 Stabilization of hypoallergenic, hyperdigestible previously reduced proteins |
| 08/15/2002 | WO2002062297A2 Methods and compositions for modulating gluconeogenesis using pgc-1 |
| 08/15/2002 | WO2002062207A2 Myeloperoxidase, a risk indicator for cardiovascular disease |
| 08/15/2002 | WO2002062205A2 Methods for diagnosing and treating heart disease |
| 08/15/2002 | WO2002062204A2 Methods for diagnosing and treating heart disease |
| 08/15/2002 | WO2002062201A2 Rare event detection system |
| 08/15/2002 | WO2002062197A2 Markers for disease susceptibility and targets for therapy |
| 08/15/2002 | WO2002062134A1 Human sphingosine-1-phosphate phosphatase |
| 08/15/2002 | WO2002051858A3 Antisense modulation of chk2 expression |
| 08/15/2002 | WO2002049502A3 Methods for diagnosing and treating pediatric neoplasms |
| 08/15/2002 | WO2002047266A3 Transient electrical signal based methods and devices for characterizing molecular interaction and/or motion in a sample |
| 08/15/2002 | WO2002046404A9 Schizophrenia-related voltage-gated ion channel gene and protein |
| 08/15/2002 | WO2002046363A3 Improved methods for gene expression monitoring on electronic microarrays |
| 08/15/2002 | WO2002038035A3 Methods for inhibiting pain |
| 08/15/2002 | WO2002034109A3 A reagent and kit for determining global coagulability and hemostatic potential |
| 08/15/2002 | WO2002032937A3 Neuromedin u delta |
| 08/15/2002 | WO2002032419A3 Methods for modulating bladder function |
| 08/15/2002 | WO2002029379A3 Computer system for designing oligonucleotides used in biochemical methods |
| 08/15/2002 | WO2002026376A3 High density arrays |
| 08/15/2002 | WO2002022781A3 Non-nucleoside reverse transcriptase inhibitor as antiretroviral therapy |
| 08/15/2002 | WO2002022160A3 The diagnosis, prevention, amelioration and/or treatment of disturbed immune function induced by disturbed lipid metabolism |